Kintegral Advisory’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $571K | Hold |
2,930
| – | – | 0.05% | 209 |
|
|
2026
Q1 | $658K | Sell |
2,930
-130
| -4% | -$32.4K | 0.06% | 198 |
|
|
2025
Q4 | $737K | Sell |
3,060
-83
| -3% | -$21.2K | 0.06% | 198 |
|
|
2025
Q3 | $860K | Sell |
3,143
-14
| -0.4% | -$3.82K | 0.07% | 188 |
|
|
2025
Q2 | $815K | Sell |
3,157
-5
| -0.2% | -$1.19K | 0.07% | 198 |
|
|
2025
Q1 | $708K | Sell |
3,162
-11
| -0.3% | -$2.57K | 0.07% | 201 |
|
|
2024
Q4 | $726K | Sell |
3,173
-148
| -4% | -$35.6K | 0.07% | 199 |
|
|
2024
Q3 | $811K | Sell |
3,321
-43
| -1% | -$9.61K | 0.07% | 197 |
|
|
2024
Q2 | $644K | Sell |
3,364
-1,829
| -35% | -$371K | 0.06% | 211 |
|
|
2024
Q1 | $1.03M | Sell |
5,193
-16
| -0.3% | -$2.93K | 0.1% | 160 |
|
|
2023
Q4 | $896K | Sell |
5,209
-34
| -0.6% | -$5.22K | 0.1% | 167 |
|
|
2023
Q3 | $775K | Sell |
5,243
-3
| -0.1% | -$542 | 0.1% | 174 |
|
|
2023
Q2 | $1.15M | Hold |
5,246
| – | – | 0.14% | 145 |
|
|
2023
Q1 | $1.15M | Sell |
5,246
-282
| -5% | -$61.2K | 0.15% | 145 |
|
|
2022
Q4 | $1.15M | Buy |
5,528
+1,666
| +43% | +$366K | 0.15% | 146 |
|
|
2022
Q3 | $843K | Hold |
3,862
| – | – | 0.12% | 151 |
|
|
2022
Q2 | $810K | Buy |
3,862
+82
| +2% | +$17.5K | 0.11% | 162 |
|
|
2022
Q1 | $917K | Buy |
3,780
+84
| +2% | +$20.3K | 0.1% | 165 |
|
|
2021
Q4 | $963K | Hold |
3,696
| – | – | 0.1% | 164 |
|
|
2021
Q3 | $974K | Hold |
3,696
| – | – | 0.11% | 158 |
|
|
2021
Q2 | $911K | Hold |
3,696
| – | – | 0.11% | 163 |
|
|
2021
Q1 | $717K | Hold |
3,696
| – | – | 0.09% | 185 |
|
|
2020
Q4 | $786K | Hold |
3,696
| – | – | 0.11% | 165 |
|
|
2020
Q3 | $634K | Sell |
3,696
-119
| -3% | -$22K | 0.1% | 174 |
|
|
2020
Q2 | $732K | Hold |
3,815
| – | – | 0.12% | 153 |
|
|
2020
Q1 | $562K | Buy |
3,815
+428
| +13% | +$68.2K | 0.11% | 164 |
|
|
2019
Q4 | $525K | Hold |
3,387
| – | – | 0.1% | 192 |
|
|
2019
Q3 | $458K | Hold |
3,387
| – | – | 0.09% | 201 |
|
|
2019
Q2 | $413K | Hold |
3,387
| – | – | 0.08% | 217 |
|
|
2019
Q1 | $352K | Sell |
3,387
-104
| -3% | -$10.7K | 0.07% | 228 |
|
|
2018
Q4 | $398K | Buy |
+3,491
| New | +$374K | 0.12% | 152 |
|
Other funds holding RMD
Kintegral Advisory's RMD Position: Q2 2026 in Review
Kintegral Advisory held its ResMed (RMD) position steady in Q2 2026 at 2,930 shares worth $571K. The position accounts for 0.05% of the portfolio, ranked #209.
Kintegral Advisory first reported a position in RMD in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.15M in Q4 2022. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Kintegral Advisory held 2,930 shares of ResMed worth $571K as of Q2 2026.
- Kintegral Advisory left its ResMed share count unchanged in Q2 2026.
- ResMed made up 0.05% of Kintegral Advisory's portfolio in Q2 2026, its #209 holding.
- Kintegral Advisory first reported a position in ResMed in Q4 2018 and has held it in 31 quarters since.
- Kintegral Advisory's ResMed position peaked at $1.15M in Q4 2022.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.